Staphylococcal resistance and oral cephalosporins for skin and skin structure infections

Cutis

Volumn 73, Issue 5 SUPPL., 2004, Pages 19-20

  Joseph, Warren S ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Med Pharm   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CEFADROXIL; CEFALEXIN; CEFDINIR; CEFDITOREN; CEFPODOXIME PROXETIL; CEFPROZIL; CEFRADINE; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; LORACARBEF;

CONFERENCE PAPER; DRUG EFFICACY; DRUG INDICATION; HUMAN; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; HUMANS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 2642512106     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. WA Petri Jr. Antimicrobial agents: penicillins, cephalosporins, and other β-lactam antibiotics. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:1189-1218.
2. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-139.
3. Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000.
4. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:565-567.
5. Joseph WS. Handbook of Lower Extremity Infections. 2nd ed. St. Louis, Mo: Churchill Livingstone; 2003.